Christopher D. Maggiore - Feb 9, 2022 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Christopher D. Maggiore
Stock symbol
ZIVO
Transactions as of
Feb 9, 2022
Transactions value $
$340,098
Form type
4
Date filed
2/16/2022, 05:02 AM
Previous filing
Jan 14, 2022
Next filing
Dec 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZIVO Common Stock Purchase $101K +28.4K +3.98% $3.55 740K Feb 9, 2022 Direct F1
transaction ZIVO Common Stock Purchase $65.5K +18K +2.43% $3.64 758K Feb 10, 2022 Direct F2
transaction ZIVO Common Stock Purchase $174K +45K +5.93% $3.87 803K Feb 11, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.4899 to $3.60 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 (2)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.48 to $3.70 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 (3)The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7199 to $4.07 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.